Indications for heart transplantation: focus on advanced heart failure
DOI:
https://doi.org/10.14739/2310-1210.2024.5.305310Keywords:
heart failure, clinical progression, heart transplantation, transplantationAbstract
Heart failure is one of the most important medical and social problems. Despite recent successes in the treatment of this disease, which have been achieved with guideline-recommended medical treatment, some patients become insensitive to the interventions. Refractoriness to treatment recommended by the guidelines means that patients cannot hope for symptom relief or prolongation of life. These individuals develop the phase of advanced heart failure and have the worst survival rates compared to other stages of chronic heart failure. In the absence of contraindications, heart transplantation is indicated for this group of patients. In the recent years, organ transplantation has been legalized and the work of cadaver donation institutions has been organized in Ukraine. These changes helped to significantly increase the annual number of heart transplantations in the country.
The aim of the work is to systematize current knowledge about end-stage heart failure, to provide methods to timely diagnose advanced heart failure and indications for referral for heart transplantation.
At least every tenth patient with heart failure may deteriorate to the advanced stage. The article details clinical trajectories of patients with heart failure, and a particular emphasis has been given to refractory patients in accordance with present guidelines and recommendations. The main pathophysiological links and corresponding clinical manifestations of advanced heart failure have been outlined. The problems of life expectancy prognosing and possible predictors of refractoriness to the treatment recommended by the guidelines have been discussed. Current diagnostic criteria for advanced heart failure have been specified, including physical, laboratory and imaging methods of examination. The principles of differential diagnosis, especially between symptomatic and advanced heart failure, have been considered. Triggers for referring patients to a heart transplant center have been detailed. Current guidelines for heart transplantation related to advanced heart failure have been given.
Conclusions. Advanced heart failure is the progression of heart failure due to refractoriness to treatment. Diagnostic criteria for advanced heart failure have been developed relatively recently. This diagnosis requires an utmost understanding of pathophysiology and skills to examine cardiac patients using modern tools. Due to the extremely unfavorable prognosis, diagnosis of advanced heart failure is an absolute indication for referral to a heart transplant center.
References
Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study. J Am Coll Cardiol. 2020;76(25):2982-3021. doi: https://doi.org/10.1016/J.JACC.2020.11.010
Kovtun G, Kaniura O. [Scientific substantiation of conceptual directions of development of the system of donation and transplantation]. The ukrainian scientific medical youth journal. 2024;(1):169-74. Ukrainian. doi: https://doi.org/10.32345/USMYJ.1(144).2024.169-174
Hrytsko RY, Furtak II. [Modern aspects of public administration in relation to transplantation in the context of European integration of Ukraine]. Public Management and Administration in Ukraine. 2018;7:39-45. Ukrainian. Available from: https://pag-journal.iei.od.ua/archives/2018/7-2018/10.pdf
Ukrainian center of transplant-coordination. Statistics [Internet]. 2024 [cited 2024 Jul 15]. Ukrainian. Available from: https://utcc.gov.ua/statystyka/
Bozkurt B, Coats AJ, Tsutsui H, Abdelhamid M, Adamopoulos S, Albert N, et al. Universal Definition and Classification of Heart Failure: A Report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure. J Card Fail. 2021:S1071-9164(21)00050-6. doi: https://doi.org/10.1016/j.cardfail.2021.01.022
Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145(18):E895-1032. doi: https://doi.org/10.1161/CIR.0000000000001063
Starling RC. Advanced heart failure: transplantation, LVADs, and beyond. Cleve Clin J Med 2013;80(1):33-40. doi: https://doi.org/10.3949/CCJM.80GR.12003
Masarone D, Kittleson M, Petraio A, Pacileo G. Advanced heart failure: state of the art and future directions. Rev Cardiovasc Med. 2022;23(2):48. doi: https://doi.org/10.31083/J.RCM2302048
Crespo-Leiro MG, Metra M, Lund LH, Milicic D, Costanzo MR, Filippatos G, et al. Advanced heart failure: a position statement of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2018;20(11):1505-35. doi: https://doi.org/10.1002/EJHF.1236
Severino P, Mather PJ, Pucci M, D’Amato A, Mariani MV, Infusino F, et al. Advanced heart failure and end-stage heart failure: Does a difference exist. Diagnostics (Basel). 2019;9(4):170. doi: https://doi.org/10.3390/DIAGNOSTICS9040170
Adams J, Zannad F. Clinical definition and epidemiology of advanced heart failure. Am Heart J. 1998;135(6 Pt 2 Su):S204-15. doi: https://doi.org/10.1016/S0002-8703(98)70251-0
Subramaniam AV, Weston SA, Killian JM, Schulte PJ, Roger VL, Redfield MM, et al. Development of Advanced Heart Failure: A Population-Based Study. Circ Heart Fail. 2022;15(5):e009218. doi: https://doi.org/10.1161/CIRCHEARTFAILURE.121.009218
Kalogeropoulos AP, Samman-Tahhan A, Hedley JS, McCue AA, Bjork JB, Markham DW, et al. Progression to Stage D Heart Failure Among Outpatients With Stage C Heart Failure and Reduced Ejection Fraction. JACC Heart Fail. 2017;5(7):528-37. doi: https://doi.org/10.1016/J.JCHF.2017.02.020
Kepinska K, Adamczak DM, Kaluzna-Oleksy M. Advanced heart failure: A review. Adv Clin Exp Med. 2019;28(8):1143-8. doi: https://doi.org/10.17219/ACEM/103669
McDonagh TA, Metra M, Adamo M, Baumbach A, Böhm M, Burri H, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599-726. doi: https://doi.org/10.1093/EURHEARTJ/EHAB368
Baudry G, Coutance G, Dorent R, Bauer F, Blanchart K, Boignard A, et al. Prognosis value of Forrester’s classification in advanced heart failure patients awaiting heart transplantation. ESC Heart Fail. 2022;9(5):3287-97. doi: https://doi.org/10.1002/EHF2.14037
Pagnesi M, Lombardi CM, Chiarito M, Stolfo D, Baldetti L, Loiacono F, et al. Prognostic impact of the updated 2018 HFA-ESC definition of advanced heart failure: results from the HELP-HF registry. Eur J Heart Fail. 2022;24(9):1493-503. doi: https://doi.org/10.1002/EJHF.2561
Yu DS, Li PW, Chong SO. Symptom cluster among patients with advanced heart failure: a review of its manifestations and impacts on health outcomes. Curr Opin Support Palliat Care. 2018;12:16-24. doi: https://doi.org/10.1097/SPC.0000000000000316
Martínez-Sellés M, Grodzicki T. Modification of Cardiovascular Drugs in Advanced Heart Failure: A Narrative Review. Front Cardiovasc Med. 2022;9:883669. doi: https://doi.org/10.3389/FCVM.2022.883669
Jha SR, Ha HS, Hickman LD, Hannu M, Davidson PM, Macdonald PS, et al. Frailty in advanced heart failure: a systematic review. Heart Fail Rev. 2015;20(5):553-60. doi: https://doi.org/10.1007/S10741-015-9493-8
Mehra MR, Gustafsson F. Left Ventricular Assist Devices at the Crossroad of Innovation in Advanced Heart Failure. J Card Fail. 2021;27(11):1291-4. doi: https://doi.org/10.1016/J.CARDFAIL.2021.06.003
Shakoor A, Abou Kamar S, Malgie J, Kardys I, Schaap J, de Boer RA, et al. The different risk of new-onset, chronic, worsening, and advanced heart failure: A systematic review and meta-regression analysis. Eur J Heart Fail. 2024;26(2):216-29. doi: https://doi.org/10.1002/EJHF.3048
Dunlay SM, Roger VL, Killian JM, Weston SA, Schulte PJ, Subramaniam AV, et al. Advanced Heart Failure Epidemiology and Outcomes: A Population-Based Study. JACC Heart Fail 2021;9(10):722-32. doi: https://doi.org/10.1016/J.JCHF.2021.05.009
Goldraich L, Beck-da-Silva L, Clausell N. Are scores useful in advanced heart failure? Expert Rev Cardiovasc Ther. 2009;7(8):985-97. doi: https://doi.org/10.1586/ERC.09.68
Szczurek-Wasilewicz W, Gąsior M, Skrzypek M, Kurkiewicz K, Szyguła-Jurkiewicz B. Predictors of 1-year mortality in ambulatory patients with advanced heart failure awaiting heart transplant. Pol Arch Intern Med. 2022;132(2):16151. doi: https://doi.org/10.20452/PAMW.16151
Kato TS, Stevens GR, Jiang J, Christian Schulze P, Gukasyan N, Lippel M, et al. Risk stratification of ambulatory patients with advanced heart failure undergoing evaluation for heart transplantation. J Heart Lung Transplant. 2013;32(3):333-40. doi: https://doi.org/10.1016/J.HEALUN.2012.11.026
Muñoz MA, Calero E, Duran J, Navas E, Alonso S, Argemí N, et al. Short-Term Mortality in Patients with Heart Failure at the End-of-Life Stages: Hades Study. J Clin Med. 2022;11(9):2280. doi: https://doi.org/10.3390/JCM11092280/S1
Marcondes-Braga FG, Bonatto MG, Andrade CR, Bacal F. Implementation of Heart Transplantation Program to Advanced Heart Failure Patients in Brazil. Curr Heart Fail Rep. 2019;16(1):7-11. doi: https://doi.org/10.1007/S11897-019-0418-Z
Maddox TM, Januzzi JL, Allen LA, Breathett K, Brouse S, Butler J, et al. 2024 ACC Expert Consensus Decision Pathway for Treatment of Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2024;83(15):1444-88. doi: https://doi.org/10.1016/J.JACC.2023.12.024
Mehra MR, Canter CE, Hannan MM, Semigran MJ, Uber PA, Baran DA, et al. The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: A 10-year update. J Heart Lung Transplant. 2016 Jan;35(1):1-23. doi: https://doi.org/10.1016/j.healun.2015.10.023
Downloads
Additional Files
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
